Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

11009	Companies
241214	Keywords
169764	Articles
129842	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 03/27/2024 at 11:30, 2 years 5 months ago

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Moderna announces successful clinical readouts for fourth respiratory vaccine candidate meeting Phase 3 endpoints and provides updates on vaccine portfolios, clinical trials, and financial agreements at fifth Vaccines Day event

Clinical Trials Moderna Vaccine Phase 3 Respiratory
BRIEF

published on 03/26/2024 at 12:05, 2 years 5 months ago

Moderna Reports Positive Results in Phase 3 Trial of New COVID-19 Vaccine

Public Health COVID-19 Vaccine Moderna Phase 3 Trial MRNA-1283
PRESS RELEASE

published on 03/26/2024 at 12:00, 2 years 5 months ago

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Moderna's mRNA-1283 shows higher immune response than mRNA-1273.222 in Phase 3 trial. Next-generation vaccine offers longer shelf life and storage benefits, paving way for flu-COVID combo vaccine, mRNA-1083

COVID-19 Vaccine Moderna Phase 3 Trial MRNA-1283 MRNA-1273.222
BRIEF

published on 02/29/2024 at 13:00, 2 years 6 months ago

Moderna Announces Fifth Annual Vaccine-Focused Investor Event

Investors Webcast Moderna Investor Event MRNA Vaccines
PRESS RELEASE

published on 02/29/2024 at 13:00, 2 years 6 months ago

Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024
Moderna, Inc. announces its fifth annual Investor Event focusing on vaccines and business updates on March 27, 2024. Presentation at 9:00 a.m. ET. Live webcast available on the Moderna website

Webcast MRNA Medicine Moderna Investor Event MRNA Vaccines
BRIEF

published on 02/28/2024 at 13:00, 2 years 6 months ago

Moderna announces participation in investor conferences

Investor Conferences Webcast MRNA Technology Moderna Health
PRESS RELEASE

published on 02/28/2024 at 13:00, 2 years 6 months ago

Moderna to Present at Upcoming Investor Conferences in March 2024
Moderna, Inc. to participate in upcoming investor conferences and showcase advancements in mRNA technology. Visit investors.modernatx.com for webcast details

Investor Conferences Healthcare Moderna Inc. MRNA Technology COVID-19 Vaccines
BRIEF

published on 02/22/2024 at 12:30, 2 years 6 months ago

Moderna announces mixed financial results for 2023 and optimistic outlook for 2024

2023 Financial Results 2024 Forecasts Moderna RSV Vaccine Research Pipeline
PRESS RELEASE

published on 02/22/2024 at 12:30, 2 years 6 months ago

Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $2.8 billion with a GAAP net income of $217 million. Expects regulatory approvals for RSV vaccine and forecasts 2024 product sales of $4 billion

Financial Results Moderna Inc. RSV Vaccine Product Sales Regulatory Approvals
PRESS RELEASE

published on 02/07/2024 at 06:00, 2 years 7 months ago

Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Moderna, Inc.'s CEO Stéphane Bancel elected to National Academy of Engineering for distinguished contributions to engineering and manufacturing of pharmaceutical products, including COVID-19 vaccine. Company has 45 mRNA therapeutic and vaccine programs in pipeline

Moderna Inc COVID-19 Vaccine Stéphane Bancel National Academy Of Engineering MRNA Technology

Accesswire

Published on 09/17/2026 at 10:00, 42 minutes ago

Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/16/2026 at 23:45, 10 hours 57 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 13 hours 12 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 17 hours 47 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 19 hours 42 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 10:05, 36 minutes ago

Geely Farizon Debuts Full-Spectrum Electric Commercial Vehicle Lineup at IAA Transportation 2026
Published on 09/17/2026 at 10:05, 36 minutes ago

Avalara Appoints Claire Goad as General Manager of E-Invoicing and Live Reporting
Published on 09/17/2026 at 09:49, 53 minutes ago

Kirchhoff analysis: Most AGM speeches in the SDAX are overly complex and lack accessibility
Published on 09/17/2026 at 09:30, 1 hour 12 minutes ago

Allane Mobility Group and DEKRA expand their network of return locations
Published on 09/17/2026 at 09:28, 1 hour 13 minutes ago

KNDS THL20 TURRETS SELECTED FOR INDIA’S NEW LIGHT COMBAT HELICOPTER PROGRAM

Les Echos

Published on 09/16/2026 at 20:46, 13 hours 56 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 16 hours 57 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 16 hours 57 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 3 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 16 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE